Your browser doesn't support javascript.
loading
Loss of neuronal lysosomal acid lipase drives amyloid pathology in Alzheimer's disease.
Barnett, Alexandra M; Dawkins, Lamar; Zou, Jian; McNair, Elizabeth; Nikolova, Viktoriya D; Moy, Sheryl S; Sutherland, Greg T; Stevens, Julia; Colie, Meagan; Katemboh, Kemi; Kellner, Hope; Damian, Corina; DeCastro, Sagan; Vetreno, Ryan P; Coleman, Leon G.
Afiliación
  • Barnett AM; University of North Carolina at Chapel Hill School of Medicine, Department of Pharmacology, Chapel Hill, NC.
  • Dawkins L; Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC.
  • Zou J; University of North Carolina at Chapel Hill School of Medicine, Department of Pharmacology, Chapel Hill, NC.
  • McNair E; Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC.
  • Nikolova VD; University of North Carolina at Chapel Hill School of Medicine, Department of Pharmacology, Chapel Hill, NC.
  • Moy SS; Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC.
  • Sutherland GT; University of North Carolina at Chapel Hill School of Medicine, Department of Pharmacology, Chapel Hill, NC.
  • Stevens J; Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC.
  • Colie M; University of North Carolina at Chapel Hill School of Medicine, Department of Psychiatry, Chapel Hill, NC.
  • Katemboh K; University of North Carolina at Chapel Hill, Carolina Institute for Developmental Disabilities, Chapel Hill, NC.
  • Kellner H; University of North Carolina at Chapel Hill School of Medicine, Department of Psychiatry, Chapel Hill, NC.
  • Damian C; University of North Carolina at Chapel Hill, Carolina Institute for Developmental Disabilities, Chapel Hill, NC.
  • DeCastro S; New South Wales Brain Tissue Resource Centre and Charles Perkins Centre, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdon, Australia.
  • Vetreno RP; New South Wales Brain Tissue Resource Centre and Charles Perkins Centre, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdon, Australia.
  • Coleman LG; University of North Carolina at Chapel Hill School of Medicine, Department of Pharmacology, Chapel Hill, NC.
bioRxiv ; 2024 Jun 10.
Article en En | MEDLINE | ID: mdl-38915509
ABSTRACT
Underlying drivers of late-onset Alzheimer's disease (LOAD) pathology remain unknown. However, multiple biologically diverse risk factors share a common pathological progression. To identify convergent molecular abnormalities that drive LOAD pathogenesis we compared two common midlife risk factors for LOAD, heavy alcohol use and obesity. This revealed that disrupted lipophagy is an underlying cause of LOAD pathogenesis. Both exposures reduced lysosomal flux, with a loss of neuronal lysosomal acid lipase (LAL). This resulted in neuronal lysosomal lipid (NLL) accumulation, which opposed Aß localization to lysosomes. Neuronal LAL loss both preceded (with aging) and promoted (targeted knockdown) Aß pathology and cognitive deficits in AD mice. The addition of recombinant LAL ex vivo and neuronal LAL overexpression in vivo prevented amyloid increases and improved cognition. In WT mice, neuronal LAL declined with aging and correlated negatively with entorhinal Aß. In healthy human brain, LAL also declined with age, suggesting this contributes to the age-related vulnerability for AD. In human LOAD LAL was further reduced, correlated negatively with Aß1-42, and occurred with polymerase pausing at the LAL gene. Together, this finds that the loss of neuronal LAL promotes NLL accumulation to impede degradation of Aß in neuronal lysosomes to drive AD amyloid pathology.